Orange: Be mindful of portions, as these are calorie-dense and may contribute to digestive discomfort for some
Your goals deserve real medical support
[27] Warnings/Precautions: [edit] Pancreatitis has been reported in clinical trials, do not continue usage if any pancreatitis has been spotted or confirmed, other therapies should be considered in patients with a prior history of pancreatitis Hypoglycemia has been noted when used in combination with an insulin secretagogue or insulin, consider lowering the usage of insulin in order to reduce the risk of hypoglycemia Hypersensitivity reactions such as anaphylactic reactions and angioedema have occurred
Li, P., Gu, M
In the phase 3, 72-week study, 1,197 patients with F2-3 MASH were randomized 2:1 to subcutaneous semaglutide 2.4 mg/week or placebo, with 62.9% achieving steatohepatitis resolution and 36.8% achieving reduction in fibrosis compared to 34.3% steatohepatitis resolution and 22.4% fibrosis reduction in those on placebo [7]
Individuals should seek medical attention if they have prolonged nausea or vomiting, or an inability to take in fluids